COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia Research Letter

   

Authors:	Roeker, L. E.; Knorr, D. A.; Thompson, M. C.; Nivar, M.; Lebowitz, S.; Peters, N.; Deonarine, I. Jr; Momotaj, S.; Sharan, S.; Chanlatte, V.; Hampton, B.; Butala, L.; Amato, L.; Richford, A.; Lunkenheimer, J.; Battiato, K.; Laudati, C.; Mato, A. R.
Title:	COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia
Keywords:	adult; clinical article; controlled study; treatment response; aged; drug efficacy; treatment duration; clinical practice; multiple cycle treatment; retrospective study; immune response; vaccination; chronic lymphatic leukemia; logistic regression analysis; serology; antibody production; immunocompromised patient; cd20 antibody; very elderly; human; male; female; article; venetoclax; bruton tyrosine kinase inhibitor; sars-cov-2 antibody; comirnaty
Journal Title:	Leukemia
Volume:	35
Issue:	9
ISSN:	0887-6924
Publisher:	Nature Publishing Group
Date Published:	2021-09-01
Start Page:	2703
End Page:	2705
Language:	English
DOI:	10.1038/s41375-021-01270-w
PUBMED:	33986431
PROVIDER:	scopus
PMCID:	PMC8118367
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85105827201&doi=10.1038%2fs41375-021-01270-w&partnerID=40&md5=a98dd1f158b37e9dc3a621acf6c3c4ad
Notes:	Article -- Export Date: 1 October 2021 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/187206